BDTX: Black Diamond Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-07-27 | New 13G stake | BlackRock, Inc. | 6.70% | SEC |
Institutional ownership (Q2 2026)
96 institutions reported holding $52.58M of Black Diamond Therapeutics, Inc. on Form 13F (104 the quarter before). 25 opened a new position and 32 sold out. Shares held by institutions: -9%.
| Largest holders | Shares | Value |
|---|---|---|
| NEA Management Company, LLC | 4,448,757 | $8.23M |
| BlackRock, Inc. | 3,917,088 | $7.25M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,125,270 | $3.93M |
| RENAISSANCE TECHNOLOGIES LLC | 1,962,394 | $3.63M |
| Defilade Capital Management, L.P. | 1,674,999 | $3.10M |
| DIMENSIONAL FUND ADVISORS LP | 1,365,384 | $2.53M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,218,171 | $2.25M |
| Connor, Clark & Lunn Investment Management Ltd. | 1,092,885 | $2.02M |
| AWM Investment Company, Inc. | 1,000,000 | $1.85M |
| MARSHALL WACE, LLP | 896,602 | $1.66M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.